I'm generally against pharmaceutical companies charging ridiculous prices for their drugs, but we've benefited from the fact that they use this money to pursue risky research opportunities. If the chance at a big payoff wasn't there, big pharma might not have had this in the hopper. Government funding alone probably can't incentivize pharma to continue pursuing long-shot bets at their current level. Now I have to think about which option I would prefer- cheaper prescriptions or a better chance at being prepared for catastrophic events.
It took two days to develop Moderna’s vaccine
21–30 of 339 posts
Re: It took two days to develop Moderna’s vaccine
#22Just curious -- would it be that much harder to develop a vaccine that was itself contagious? Recipients would expel the vaccine in their own respiration?
"The OPV is less expensive and easier to administer, and can spread immunity beyond the person vaccinated, creating contact immunity. It has been the predominant vaccine used. However, under conditions of long-term vaccine virus circulation in under-vaccinated populations, mutations can reactivate the virus..."
Re: It took two days to develop Moderna’s vaccine
#23I wonder if any, or if many, Moderna employees have been walking around off-the-books immunized since January. I know I would've been tempted.
Re: It took two days to develop Moderna’s vaccine
#24Question: what would be the likely reasons for that? In particular, is it almost certainly going to be due to whatever carries the mRNA, or could the mRNA itself be the problem?
If it is the carrier in which potential safety issues lie, does that mean that once we have one successful safe mRNA vaccine for virus A, then when some new virus B comes along an mRNA vaccine for B that uses the same carrier is going to be as safe as the vaccine for virus A?
If so, does that mean for future new viruses, the mRNA approach will let us go right into effectiveness testing, skipping phase 1 safety testing?
Re: It took two days to develop Moderna’s vaccine
#25As far as I know Moderna and Biontech tried different variants of their vaccine. And to determine how well those work you have to do some animal experiments, and that is always much slower than designing and synthesizing mRNA sequences.
The mRNA vaccines were the fastest ones, and they worked better than expected. So I think there is a lot of promise in the technology, but further speedups are hard because they're in the clinical study part.
Re: It took two days to develop Moderna’s vaccine
#26Just curious -- would it be that much harder to develop a vaccine that was itself contagious? Recipients would expel the vaccine in their own respiration?
Risky, though, because if it turns out to be less benign than we thought - or mutates in such a way as to become lethal - we've just started a second pandemic.
Re: It took two days to develop Moderna’s vaccine
#27I could write Twitter in a weekend.
Re: It took two days to develop Moderna’s vaccine
#28Re: It took two days to develop Moderna’s vaccine
#29Re: It took two days to develop Moderna’s vaccine
#30The technology was years in the making. DARPA was also involved. “In October 2013, DARPA awarded Moderna up to approximately $25 million to research and develop potential mRNA medicines as a part of DARPA’s Autonomous Diagnostics to Enable Prevention and Therapeutics, or ADEPT, program”
The point being, if a novel deadly virus was discovered tomorrow, how fast could Moderna develop a potential vaccine?